Shine-On BioMedical Co (ROCO:6926) EPS (Basic) : NT$-2.39 (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Shine-On BioMedical Co EPS (Basic)?

Shine-On BioMedical Co's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was NT$-1.46. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2.39.

Shine-On BioMedical Co's EPS (Diluted) for the six months ended in Dec. 2024 was NT$-1.46. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2.39.

Shine-On BioMedical Co's EPS without NRI for the six months ended in Dec. 2024 was NT$-1.46. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -2.39.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Shine-On BioMedical Co EPS (Basic) Historical Data

The historical data trend for Shine-On BioMedical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shine-On BioMedical Co EPS (Basic) Chart

Shine-On BioMedical Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

-0.46

-0.43

-0.75

-2.39

Shine-On BioMedical Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial					-0.31	-0.26	-0.49	-0.93	-1.46

Shine-On BioMedical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Shine-On BioMedical Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-118.893	-	0)	/	49.746
	=	-2.39

Shine-On BioMedical Co's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-72.436	-	0)	/	49.692
	=	-1.46

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-2.39

Shine-On BioMedical Co (ROCO:6926) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Shine-On BioMedical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Shine-On BioMedical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Shine-On BioMedical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shine-On BioMedical Co Ltd (ROCO:6926) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 633, Section 2, Taiwan Avenue, Unit 6, 5th Floor, Xitun District, Taichung, TWN

Website

https://www.shineon-bio.com

Shine-On BioMedical Co Ltd develops drugs based on antibodies and nucleic acids. The Company researches, develops, manufactures, and distributes antibody anticancer drugs, nucleic acid anticancer drugs. The company's drug development and nucleic acid therapeutics are focused on providing patients with the most effective cancer treatment options.

Shine-On BioMedical Co Headlines

No Headlines